| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 50mg | ¥ ŧŧƝƒǵǵ | > 10 | > 10 | -- | -- | -- | -- | ¥ ŧŧƝƒǵǵ | - + |
| 100mg | ¥ ŧýȏƒǵǵ | > 10 | > 10 | -- | -- | -- | -- | ¥ ŧýȏƒǵǵ | - + |
| 50mg | ¥ Řȏǵƒǵǵ | > 10 | > 10 | -- | 1 | 1 | -- | ¥ Řȏǵƒǵǵ | - + |
| 1g | ¥ ǕýǕƒǵǵ | > 10 | > 10 | -- | 3 | 1 | ¥ ǕýǕƒǵǵ | - + | |
| 5g | ¥ ƌŘNJŘƒǵǵ | 3 | 3 | 1 | 1 | 1 | ¥ ƌŘNJŘƒǵǵ | - + | |
| 5g | ¥ ŧǵNJƌŧƒǵǵ | -- | -- | -- | -- | -- | -- | ¥ ŧǵNJƌŧƒǵǵ | - + |
| 100g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 500g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 1000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
90.37
[1]. Adkins JC, et al. Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.Drugs. 1997 Jun;53():1054-80
[]. Jin MJ, et al. Interaction of zalcitabine with human organic anion transporter 1. Pharmazie. 00 May;1(5):491-.
[3]. Alan Talevi, et al. Prediction of drug intestinal absorption by new linear and non-linear QSPR. Eur J Med Chem. 011 Jan;4(1):18-8.
[4]. Denis Fourches, et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 010 Jan;3(1):171-83.
[5]. Kaleb C Lund, et al. Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs. Antimicrob Agents Chemother. 007 Jul;51(7):531-9.
P80-P405-P501
![]()